135 related articles for article (PubMed ID: 3710299)
1. Biochemical and pharmacological studies on the interaction of PK 10169 and its subfractions with human platelets.
Brace LD; Fareed J; Tomeo J; Issleib S
Haemostasis; 1986; 16(2):93-105. PubMed ID: 3710299
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced platelet aggregation: dose/response relationships for a low molecular weight heparin derivative (PK 10169) and its subfractions.
Brace LD; Fareed J
Thromb Res; 1986 Jun; 42(6):769-82. PubMed ID: 3726798
[TBL] [Abstract][Full Text] [Related]
3. In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169).
Walenga JM; Fareed J; Hoppensteadt DA
Semin Thromb Hemost; 1985 Jan; 11(1):17-25. PubMed ID: 3883497
[TBL] [Abstract][Full Text] [Related]
4. Molecular weight of heparin versus biologic activity. Some additional considerations.
Losito R; Losito C
Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
[No Abstract] [Full Text] [Related]
5. Rationale behind the development of low molecular weight heparin derivatives.
Hirsh J; Ofosu F; Buchanan M
Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anticoagulant activities.
Blockmans D; Bounameaux H; Vermylen J; Verstraete M
Thromb Haemost; 1986 Feb; 55(1):90-3. PubMed ID: 3518134
[TBL] [Abstract][Full Text] [Related]
7. A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment.
Bratt G; Törnebohm E; Lockner D; Bergström K
Thromb Haemost; 1985 Apr; 53(2):208-11. PubMed ID: 4024029
[TBL] [Abstract][Full Text] [Related]
8. Development of heparin fractions: some overlooked considerations.
Fareed J
Semin Thromb Hemost; 1985 Apr; 11(2):227-36. PubMed ID: 3898374
[No Abstract] [Full Text] [Related]
9. Heparin, its fractions, fragments and derivatives. Some newer perspectives.
Fareed J
Semin Thromb Hemost; 1985 Jan; 11(1):1-9. PubMed ID: 3919446
[TBL] [Abstract][Full Text] [Related]
10. Effect of heparin and heparin fractions on platelet aggregation.
Salzman EW; Rosenberg RD; Smith MH; Lindon JN; Favreau L
J Clin Invest; 1980 Jan; 65(1):64-73. PubMed ID: 6243142
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously.
Bergqvist D; Hedner U; Sjörin E; Holmer E
Thromb Res; 1983 Nov; 32(4):381-91. PubMed ID: 6658720
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans.
Larsson A; Fransson LA; Lewis WE
Thromb Res; 1982 Jun; 26(6):401-9. PubMed ID: 7112518
[TBL] [Abstract][Full Text] [Related]
13. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
Vinazzer H; Woler M
Haemostasis; 1986; 16(2):106-15. PubMed ID: 2423420
[TBL] [Abstract][Full Text] [Related]
14. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
Vinazzer H; Woler M
Thromb Res; 1985 Oct; 40(2):135-46. PubMed ID: 3878009
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia.
Isenhart CE; Brandt JT
Am J Clin Pathol; 1993 Mar; 99(3):324-30. PubMed ID: 8447295
[TBL] [Abstract][Full Text] [Related]
16. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.
Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA
Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
Baruch D; Lindhout T; Wagenvoord R; Hemker HC
Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
[TBL] [Abstract][Full Text] [Related]
18. From heparin to heparin fractions and derivatives.
Coyne E
Semin Thromb Hemost; 1985 Jan; 11(1):10-2. PubMed ID: 3883496
[No Abstract] [Full Text] [Related]
19. In vitro evaluation of heparin fractions: old vs. new methods.
Walenga JM; Fareed J; Hoppensteadt D; Emanuele RM
Crit Rev Clin Lab Sci; 1986; 22(4):361-89. PubMed ID: 2936571
[TBL] [Abstract][Full Text] [Related]
20. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
Ellis V; Scully MF; Kakkar VV
Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
